Tuesday, February 14, 2012

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
FDA Approves Generic Relafen for Arthritis

Share this page
Facebook
Twitter
Stumble
Email

Save to My Home

This helped!

FDA Approves Generic Relafen for Arthritis

(RTTNews) UPDATED 2010-07-14

The U.S. Food and Drug Administration has approved a new generic version of the painkiller Relafen. The generic form of the drug, nabumetone, is generally prescribed to treat patients with osteoarthritis and rheumatoid arthritis. Officials with drugmaker Mylan Inc. say the generic formula will be available in both 500 mg and 750 mg tablets. Read full story >

See all Rheumatoid Arthritis News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media